1. Belimumab and voclosporin for lupus nephritis: final policy recommendations Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, April 16, 2021 Subject(s): Calcineurin InhibitorsImmunosuppressive AgentsLupus Nephritis -- drug therapyUnited States
